Alteogen Obtains Patent Related to Hyaluronidase Enzyme

[Asia Economy Reporter Kum Boryeong] Alteogen announced on the 28th that it has acquired a domestic patent for 'a new hyaluronidase enzyme with increased enzyme activity and thermal stability and its manufacturing method.'

Alteogen stated, "This technology is used for the development of bio-betters that convert intravenous injections to subcutaneous injections when used with existing biopharmaceuticals, antibody drugs, and anticancer agents," adding, "We have licensed the technology to two of the world's top 10 pharmaceutical companies and plan to license it further."

This content was produced with the assistance of AI translation services.